ALMIRALL, S.A. «...1112131415...» Page 14 out of 17 22/02/2021 06:22 ALMIRALL, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2020 Register number: 7179 22/02/2021 06:18 ALMIRALL, S.A. Other relevant information A webcast with analysts and institutional investors FY 2020 Register number: 7178 22/02/2021 06:03 ALMIRALL, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2020 Register number: 7177 17/02/2021 07:54 ALMIRALL, S.A. On corporate transactions Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora® Cream for treatment of Plaque Psoriasis Register number: 7128 14/01/2021 17:31 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el cuarto trimestre de 2020 Register number: 6650 15/12/2020 12:44 ALMIRALL, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 6202 15/12/2020 08:47 ALMIRALL, S.A. On business and financial situation Almirall announces FDA approval of Klisyri® (tirbanibulin), a new topical treatment for actinic keratosis Register number: 6197 18/11/2020 08:34 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el tercer trimestre de 2020 Register number: 5787 Notification modified by communication number 5105 dated 20/10/2020 (19:14) 09/11/2020 07:26 ALMIRALL, S.A. On corporate governance Consejo de Administración de la compañía Register number: 5630 09/11/2020 07:19 ALMIRALL, S.A. Interim management report La sociedad remite declaración intermedia de gestión del tercer trimestre de 2020 Register number: 5629 Page 14 out of 17 «...1112131415...»